Advertisement
Advertisement

QGEN

QGEN logo

QIAGEN N.V.

39.47
USD
+0.9
+2.33%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

39.575

+0.11
+0.27%

QIAGEN N.V. Profile

About

QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.

Info & Links

CEO

Thierry Bernard

Headquarters

HULSTERWEG 82
PL VENLO, P7 5912, NETHERLANDS

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.qiagen.com

Auditor

KPMG AG Wirtschaftspr¿fungsgesellschaft

Share holders

0

Employees

5,967

QIAGEN N.V. Statistics

Valuation Measures

Market Capitalization2

8.55B

Enterprise Value

9.28B

Enterprise Value/EBITDA(ttm)

29.10

Price to Earnings Ratio(ttm)

17.55

Price to Sales(ttm)

4.40

Price to Book(mrq)

2.44

Price to Cash(ytd)

12.21

Profitability

Gross Margin(ttm)

48.49%

Operating Margin(ttm)

24.80%

Profit Margin(ttm)

4.84%

Return on Equity(ttm)

13.92%

Return on Invested Capital(ttm)

1.60%

Return on Assets(ttm)

8.40%

Income Statement

Revenue(ttm)

1.97B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

950.16M

EBITDA(ttm)3

318.92M

Net Income Available to Common(ttm)

92.93M

Diluted EPS(ttm)

0.36

Share Statistics

Beta (5Y Monthly)

0.36

52-Week Change

-10.35%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

201.89M

% Held by Insiders

9.00%

% Held by Institutions

70.00%

Balance Sheet

Total Cash(mrq)

1.15B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

1.39B

Total Debt/Equity(mrq)

54.39%

Current Ratio(mrq)

2.17%

Quick Ratio(mrq)

3.09%

Book Value Per Share(mrq)

16.34

Cash Flow

Operating Cash Flow Per Share(ytd)

2.21

Free Cash Flow(ytd)

363.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement